Background. The gut bacterial ecosystem plays a key role in the host's energy metabolism, and potentially in the host's exercise capacity, recognized as a powerful predictor of health status and risk of mortality. Objective. To deepen our understanding of the gut bacterial ecosystem relationship with host's exercise capacity and energy metabolism, we characterized the gut microbiota in a cohort of healthy humans with heterogeneous exercise capacities, and next determined the impact of fecal microbiota transplantation (FMT) from donors of this cohort on energy metabolism and exercise capacity of recipient mice. Design. 50 male normo-weight participants (from inactive to elite endurance athletes) performed food frequency questionnaire (FFQ) and exercise tests to determine exercise capacity parameters (VO2max, fat oxidation, exercise energy expenditure). Metagenomic shotgun and metabolomic analyses were performed to characterize gut microbiota ecosystem and short-chain fatty acids (SCFAs) on human and mice fecal samples. Mice performed running exercise capacity tests and metabolic parameters were determined in skeletal muscle and plasma samples. Results. While our data support that the bacterial ecosystem appears to be modestly altered between individuals with low to high exercise capacities, we report that gut bacterial alpha-diversity, density, and functional richness are significantly reduced in athletes with very high exercise capacity. By using FMT, we report that the engraftment of these atypical gut microbiota improves insulin sensitivity and muscle glycogen stores into transfected mice. Conclusion. Our data highlight promising therapeutic perspectives in fecal transplantation from human donors selected based on exercise capacity parameters.

M.H., P.C. and C.C. are employees and skateholders of Nahibu.

NCT05220657

This study was funded by the Brittany Council (#21004090), the Societe Francaise de Nutrition (SFN), Nahibu, and the French National Research Agency within the framework of the PIA France 2030 programme for EUR DIGISPORT (ANR-18-EURE-0022) and CONTINUUM (ANR-21-ESRE-0030) projects

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The national Comite de protection des personnes Ouest IV Nantes gave ethical approval for this work (ID-RCB: 2021-A02496-35)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes